Indivior Inc.

This study tested a new long-acting injectable medication called INDV-6001 for adults with moderate to severe opioid addiction. The goal was to see how the drug behaves in the body, how safe it is, and to find the best dose for future studies. Researchers compared it to existing …

This study tested two different monthly doses of a long-acting buprenorphine injection to help control opioid addiction. It involved 785 adults with moderate-to-severe opioid use disorder who were considered high-risk users. The main goal was to see which monthly dose was better …

This study observed 12 people with opioid use disorder who had been stable on long-term medication treatment for at least 9 months. Researchers wanted to see how well they could stop treatment without relapsing into opioid use or experiencing severe withdrawal. The study followed…

This study tested whether a new medicine called INDV-2000 could help people with moderate-to-severe opioid addiction stay off opioids. For 3 months, 300 participants who were starting treatment either received the new medicine or a placebo (dummy pill), while researchers tracked …

This study followed 480 adults with opioid addiction for up to 4 years to see how well SUBLOCADE injections work in real-world settings. Researchers tracked whether participants stopped using opioids, improved their symptoms, and maintained recovery over time. The goal was to und…